ELCC 2019

The 2019 European Lung Cancer Congress (ELCC), held in Geneva, Switzerland, took place on the 10–13 April. Leading researchers from around the world showcased the latest research and developments in lung cancer.

0:48
The LUNAR study: TTFields for NSCLC
Ori Farber
0:55
Tumor treating fields as an anti-mitotic therapy
Ori Farber
2:03
A STELLAR study: TTFields for malignant pleural mesothelioma
Ori Farber
3:13
Low-dose CT lung cancer screening: strengths and limitations
Yeol Kim
1:49
Multiple-line TKIs to prolong chemo-free period in EGFRm+ NSCLC
Nicolas Girard
2:50
Enhancing the efficacy of immunotherapy in lung cancer
Wolf-Hervé Fridman
4:11
K-LUCAS: implementing lung cancer screening in Korea
Yeol Kim
1:32
The IASLC: implementing personalized medicine in lung cancer
Giorgio Scagliotti
2:07
Liquid biopsy to improve NSCLC management
Laura Bonanno
1:46
Predicting response to checkpoint inhibitors and overcoming resistance in lung cancers
Giorgio Scagliotti
1:53
Overcoming the challenges of precision medicine in lung cancer
Giorgio Scagliotti
1:48
Challenges in NSCLC: acquired resistance
Laura Bonanno
1:13
Acute pulmonary toxicity in lung cancer
Marina Garassino
1:06
Phase III real-world PACIFIC-R trial for NSCLC
Nicolas Girard
1:24
Implementation of low-dose CT lung cancer screening in France
Olivier Leleu
2:18
What factors affect response to checkpoint inhibitors in lung cancer?
Wolf-Hervé Fridman
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals